| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tarsus Pharmaceuticals Inc (NASDAQ: TARS)
TARS Technical Analysis
5
| As on 31st Mar 2026 TARS STOCK Price closed @ 70.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 50.54 & Strong Buy for SHORT-TERM with Stoploss of 51.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TARSSTOCK Price
| Open | 67.58 | Change | Price | % |
| High | 71.94 | 1 Day | 3.23 | 4.83 |
| Low | 66.38 | 1 Week | 5.64 | 8.74 |
| Close | 70.15 | 1 Month | 7.37 | 11.74 |
| Volume | 651204 | 1 Year | 17.70 | 33.75 |
| 52 Week High 82.51 | 52 Week Low 38.82 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 174.40 | 5.59% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| INTC | 44.13 | 7.14% |
| APLS | 40.23 | 135.40% |
| TIRX | 0.03 | -50.00% |
| LILM | 0.05 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TARS Daily Charts |
TARS Intraday Charts |
Whats New @ Bazaartrend |
TARS Free Analysis |
|
|
TARS Important Levels Intraday
| RESISTANCE | 80.86 |
| RESISTANCE | 77.43 |
| RESISTANCE | 75.30 |
| RESISTANCE | 73.18 |
| SUPPORT | 67.12 |
| SUPPORT | 65.00 |
| SUPPORT | 62.87 |
| SUPPORT | 59.44 |
TARS Forecast April 2026
| 4th UP Forecast | 95.95 |
| 3rd UP Forecast | 87.68 |
| 2nd UP Forecast | 82.56 |
| 1st UP Forecast | 77.45 |
| 1st DOWN Forecast | 62.85 |
| 2nd DOWN Forecast | 57.74 |
| 3rd DOWN Forecast | 52.62 |
| 4th DOWN Forecast | 44.35 |
TARS Weekly Forecast
| 4th UP Forecast | 79.96 |
| 3rd UP Forecast | 76.81 |
| 2nd UP Forecast | 74.87 |
| 1st UP Forecast | 72.92 |
| 1st DOWN Forecast | 67.38 |
| 2nd DOWN Forecast | 65.43 |
| 3rd DOWN Forecast | 63.49 |
| 4th DOWN Forecast | 60.34 |
TARS Forecast2026
| 4th UP Forecast | 160.22 |
| 3rd UP Forecast | 131.33 |
| 2nd UP Forecast | 113.48 |
| 1st UP Forecast | 95.62 |
| 1st DOWN Forecast | 44.68 |
| 2nd DOWN Forecast | 26.82 |
| 3rd DOWN Forecast | 8.97 |
| 4th DOWN Forecast | -19.92 |
Tarsus Pharmaceuticals Inc ( NASDAQ USA Symbol : TARS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TARS Business Profile
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California. Address: 15440 Laguna Canyon Road, Irvine, CA, United States, 92618
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service